(Q54007642)

23 May 2018

title

Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study. (English)

1 reference

23 May 2018

1 reference

Tremaine WJ

1 reference

23 May 2018

Targan SR

1 reference

23 May 2018

author name string

Sands BE

1 reference

23 May 2018

Sandborn WJ

1 reference

23 May 2018

Rutgeerts PJ

1 reference

23 May 2018

Hanauer SB

1 reference

23 May 2018

Mayer L

1 reference

23 May 2018

Podolsky DK

1 reference

23 May 2018

publication date

1 May 2001

1 reference

23 May 2018

Inflammatory Bowel Diseases

published in

1 reference

23 May 2018

volume

1 reference

23 May 2018

issue

1 reference

23 May 2018

page(s)

83-88

1 reference

23 May 2018

Cyclosporine in severe ulcerative colitis refractory to steroid therapy

cites work

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200105000-00001

Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200105000-00001

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200105000-00001

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200105000-00001

Construction and initial characterization of a mouse-human chimeric anti-TNF antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200105000-00001

Chimeric anti-TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200105000-00001

Cortisone in ulcerative colitis; final report on a therapeutic trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200105000-00001

Treatment of ulcerative colitis with an engineered human anti-TNFalpha antibody CDP571.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200105000-00001

10.1097/00054725-200105000-00001

21 January 2018

Identifiers

DOI

1 reference

23 May 2018

1 reference

23 May 2018